NCT03198286 - Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2015

Primary Completion Date

August 1, 2015

Study Completion Date

October 31, 2016

Conditions

Stage I Breast CancerStage I Cervical CancerStage I Ovarian CancerStage I Uterine Corpus CancerStage IA Breast CancerStage IA Cervical CancerStage IA Ovarian CancerStage IA Uterine Corpus CancerStage IB Breast CancerStage IB Cervical CancerStage IB Ovarian CancerStage IB Uterine Corpus CancerStage IC Ovarian CancerStage II Breast CancerStage II Cervical CancerStage II Ovarian CancerStage II Uterine Corpus CancerStage IIA Breast CancerStage IIA Cervical CancerStage IIA Ovarian CancerStage IIB Breast CancerStage IIB Cervical CancerStage IIB Ovarian CancerStage IIC Ovarian CancerStage III Breast CancerStage III Cervical CancerStage III Ovarian CancerStage III Uterine Corpus CancerStage IIIA Breast CancerStage IIIA Cervical CancerStage IIIA Ovarian CancerStage IIIA Uterine Corpus CancerStage IIIB Breast CancerStage IIIB Cervical CancerStage IIIB Ovarian CancerStage IIIB Uterine Corpus CancerStage IIIC Breast CancerStage IIIC Ovarian CancerStage IIIC Uterine Corpus Cancer

Interventions

OTHER

Informational Intervention

Receive treatment summary and survivor care plan

Trial Locations (2)

19107

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

19602

Reading Hospital, Reading

All Listed Sponsors

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER